Brolucizumab in naive patients with occult neovascular AMD
OCT & Retina Forum 2022
Neovascular AMD after 10 years of treatment
it
Prof. Giovanni Staurenghi
AMD, therapeutic novelties for the dry form
it
Prof. Alfonso Giovannini
Structure and advancement of the DRCR network
en
Lee M. Jampol, MD
Ophtalmic clinical and reaserch activities are resuming vigorously
it
Dott. Alfredo Pece
AMD, longer intervals between treatments with new anti VEGF
it
Dr. Riccardo Sacconi
From collagen alterations to early keratoconus diagnosis
it
Dr. Luisa Pierro
Brolucizumab in naive patients with occult neovascular AMD
it
Dr. Lisa Toto
The brolucizumab treatment regimen in naive patients
it
Dr. Maria Oliva Grassi
Diabetic retinopathy: screenings with digital retinograph + AI
it
Dr. Alberto Piatti
DRS PLUS, user friendly retinography with confocal technology
it
Francesco Berti
Easier Screening and Telemedicine with DRS Plus retinograph
it
Giulia Guffanti